Rama Vision Limited (RAMAVISION.BO)
INR 94.98
(5.18%)
INR 94.98
(5.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 272.22 Million INR | -28.66% |
| 2022 | 212.38 Million INR | 32.1% |
| 2021 | 160.76 Million INR | 18.26% |
| 2020 | 135.94 Million INR | 12.34% |
| 2019 | 121.01 Million INR | 11.37% |
| 2018 | 108.66 Million INR | 18.04% |
| 2017 | 92.05 Million INR | 6.53% |
| 2016 | 86.41 Million INR | 10.9% |
| 2015 | 77.92 Million INR | -18.97% |
| 2014 | 96.16 Million INR | 17.47% |
| 2013 | 81.86 Million INR | 4.96% |
| 2012 | 77.99 Million INR | 31.91% |
| 2011 | 59.13 Million INR | 10.88% |
| 2010 | 53.32 Million INR | 29.17% |
| 2009 | 41.28 Million INR | 1.29% |
| 2008 | 40.75 Million INR | 36.76% |
| 2007 | 29.8 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 57.11 Million INR | 3.15% |
| 2023 Q4 | 55.37 Million INR | 46.51% |
| 2023 Q3 | 37.79 Million INR | -36.0% |
| 2023 FY | 151.52 Million INR | -28.66% |
| 2023 Q2 | 59.05 Million INR | 9.41% |
| 2023 Q1 | 53.97 Million INR | 0.3% |
| 2022 Q2 | 53.76 Million INR | 10.41% |
| 2022 FY | 212.38 Million INR | 32.1% |
| 2022 Q4 | 53.81 Million INR | -4.09% |
| 2022 Q3 | 56.1 Million INR | 4.34% |
| 2022 Q1 | 48.69 Million INR | 1.67% |
| 2021 FY | 160.76 Million INR | 18.26% |
| 2021 Q4 | 47.89 Million INR | 11.48% |
| 2021 Q1 | 32.17 Million INR | -14.33% |
| 2021 Q2 | 37.73 Million INR | 17.29% |
| 2021 Q3 | 42.96 Million INR | 13.86% |
| 2020 Q1 | 26.55 Million INR | -1.5% |
| 2020 FY | 135.94 Million INR | 12.34% |
| 2020 Q4 | 37.55 Million INR | 7.18% |
| 2020 Q3 | 35.03 Million INR | -4.8% |
| 2020 Q2 | 36.8 Million INR | 38.58% |
| 2019 Q1 | 31.13 Million INR | 18.34% |
| 2019 Q4 | 26.96 Million INR | -12.2% |
| 2019 FY | 121.01 Million INR | 11.37% |
| 2019 Q2 | 32.21 Million INR | 3.48% |
| 2019 Q3 | 30.7 Million INR | -4.68% |
| 2018 Q2 | 26.79 Million INR | -0.26% |
| 2018 Q1 | 26.86 Million INR | 33.16% |
| 2018 Q4 | 26.3 Million INR | -8.33% |
| 2018 FY | 108.66 Million INR | 18.04% |
| 2018 Q3 | 28.69 Million INR | 7.11% |
| 2017 Q4 | 20.17 Million INR | -10.85% |
| 2017 Q2 | 31.83 Million INR | 82.72% |
| 2017 Q1 | 17.42 Million INR | -22.65% |
| 2017 FY | 92.05 Million INR | 6.53% |
| 2017 Q3 | 22.62 Million INR | -28.92% |
| 2016 Q1 | 21.47 Million INR | 18.41% |
| 2016 FY | 86.41 Million INR | 10.9% |
| 2016 Q4 | 22.52 Million INR | 0.5% |
| 2016 Q3 | 22.41 Million INR | 12.05% |
| 2016 Q2 | 20 Million INR | -6.84% |
| 2015 FY | 77.92 Million INR | -18.97% |
| 2015 Q4 | 18.13 Million INR | -5.14% |
| 2015 Q3 | 19.11 Million INR | -2.68% |
| 2015 Q2 | 19.64 Million INR | -6.6% |
| 2015 Q1 | 21.03 Million INR | -69.58% |
| 2014 Q2 | 27.19 Million INR | 10.9% |
| 2014 FY | 96.16 Million INR | 17.47% |
| 2014 Q4 | 69.13 Million INR | 189.79% |
| 2014 Q3 | 23.85 Million INR | -12.28% |
| 2014 Q1 | 24.52 Million INR | 18.07% |
| 2013 FY | 81.86 Million INR | 4.96% |
| 2013 Q1 | 16.97 Million INR | -18.46% |
| 2013 Q2 | 20.42 Million INR | 20.34% |
| 2013 Q3 | 20.84 Million INR | 2.04% |
| 2013 Q4 | 20.77 Million INR | -0.33% |
| 2012 Q3 | 20.84 Million INR | 22.88% |
| 2012 Q4 | 20.81 Million INR | -0.13% |
| 2012 FY | 77.99 Million INR | 31.91% |
| 2012 Q1 | 19.38 Million INR | 24.38% |
| 2012 Q2 | 16.95 Million INR | -12.52% |
| 2011 Q2 | 14.08 Million INR | -1.29% |
| 2011 Q1 | 14.26 Million INR | 0.0% |
| 2011 FY | 59.13 Million INR | 10.88% |
| 2011 Q4 | 15.58 Million INR | 2.55% |
| 2011 Q3 | 15.19 Million INR | 7.93% |
| 2010 FY | 53.32 Million INR | 29.17% |
| 2009 FY | 41.28 Million INR | 1.29% |
| 2008 Q4 | 9.49 Million INR | 0.0% |
| 2008 FY | 40.75 Million INR | 36.76% |
| 2007 FY | 29.8 Million INR | 0.0% |
| 2007 Q4 | 8.44 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 142.31 Million INR | -91.287% |
| Checkpoint Trends Limited | 11.3 Million INR | -2307.079% |
| Everest Organics Limited | 426.16 Million INR | 36.122% |
| GUJARAT INJECT (KERALA) LTD. | 3.85 Million INR | -6965.004% |
| NATURO INDIABULL LIMITED | 21.45 Million INR | -1168.878% |
| NEXUS SURGICAL AND MEDICARE LI | 26.38 Million INR | -931.649% |
| Rajnish Wellness Limited | 56.65 Million INR | -380.513% |
| Vivo Bio Tech Limited | 416.01 Million INR | 34.564% |